成田(野田) 翔子

Noda-Narita Shoko

論文 (11件)：

Shoko Noda-Narita, Tomoyuki Naito, Hibiki Udagawa, Koichi Goto, Taichi Miyawaki, Nobuaki Mamesaya, Kazuhisa Nakashima, Hirotsugu Kenmotsu, Tadasuke Shimokawaji, Terufumi Kato, et al. Nivolumab-induced radiation recall pneumonitis in non-small-cell lung cancer patients with thoracic radiation therapy. Cancer science. 2022
Shoko Noda-Narita, Mami Kanzaki, Yoshikazu Uesaka, Tatsuya Suwabe, Keiichi Kinowaki, Yuhji Marui, Junichi Hoshino, Naoki Sawa, Yoshifumi Ubara. Paraneoplastic Polymyositis Due to Renal Cell Carcinoma in a Patient with Autosomal Dominant Polycystic Kidney Disease. Internal medicine (Tokyo, Japan). 2021. 60. 22. 3577-3580
Shoko Noda-Narita, Asuka Kawachi, Ayako Okuyama, Ryo Sadachi, Akihiro Hirakawa, Yasushi Goto, Yasuhiro Fujiwara, Takahiro Higashi, Kan Yonemori. First-line treatment for lung cancer among Japanese older patients: A real-world analysis of hospital-based cancer registry data. PloS one. 2021. 16. 9. e0257489
Rurina Watanuki, Akihiko Shimomura, Shu Yazaki, Shoko Noda-Narita, Hitomi Sumiyoshi-Okuma, Tadaaki Nishikawa, Maki Tanioka, Kazuki Sudo, Tatsunori Shimoi, Emi Noguchi, et al. Survival outcomes in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer administered a therapy following trastuzumab emtansine treatment. Medicine. 2020. 99. 38. e22331
Hitomi S Okuma, Kan Yonemori, Shoko N Narita, Tamie Sukigara, Akihiro Hirakawa, Toshio Shimizu, Taro Shibata, Akira Kawai, Noboru Yamamoto, Kenichi Nakamura, et al. MASTER KEY Project: Powering Clinical Development for Rare Cancers Through a Platform Trial. Clinical pharmacology and therapeutics. 2020. 108. 3. 596-605

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

前のページに戻る